Data from 300,000 births reveal how essential biological measurements are altered by carrying and delivering a baby ...
Health professionals warn that if not properly managed, hypertensive disorders in pregnancy can lead to life-threatening ...
The Cool Down on MSN20h
FDA bars Chinese seafood companies from doing business in US after disturbing discovery found in imported clams — here's what it foundAny attempt to enter the U.S. will lead to automatic detention at the border, without any physical inspection. FDA bars ...
Sanofi’s treatment for hemophilia that can be administered as infrequently as once every other month, was approved by the US ...
Verywell Health on MSN11h
5 Outdated Blood Pressure Drugs That Are No Longer RecommendedSome blood pressure medications are not the best choice anymore, either due to their side effects or limited effectiveness.
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...
A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...
Existing treatments for endometriosis have changed little in the past 30 years and are often ineffective or have undesired ...
MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...
Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say it shouldn't be approved.
As a diabetes medication, GLP-1s are able to treat insulin resistance, something that many people with PCOS deal with. “It’s ...
CHMP recommends seven label expansions and one new approval, rejects Lilly Alzheimer's drug
CHMP backs label expansions for BMS's Opdivo, BeiGene's Tevimbra, AstraZeneca's Calquence & others; recommends approval of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback